U.S. markets open in 6 hours 14 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
107.72+0.65 (+0.61%)
At close: 4:02PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close107.07
Open107.13
Bid0.00 x 900
Ask0.00 x 900
Day's Range107.02 - 108.64
52 Week Range79.11 - 121.53
Volume4,766,816
Avg. Volume6,997,677
Market Cap190.361B
Beta (5Y Monthly)0.79
PE Ratio (TTM)29.05
EPS (TTM)3.71
Earnings DateOct 28, 2021 - Nov 01, 2021
Forward Dividend & Yield5.20 (4.86%)
Ex-Dividend DateOct 14, 2021
1y Target Est127.01
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-24% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AbbVie Inc.
    Analyst Report: AbbVie Inc.AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    15 days agoMorningstar
View more